Article info

Download PDFPDF
Evaluation of the Hematologic Safety of Same Day Versus Standard Administration (24- to 72-Hour Delay) of Pegfilgrastim in Gynecology Oncology Patients Undergoing Cytotoxic Chemotherapy

Authors

  1. Address correspondence and reprint requests to Caroline C. Billingsley, MD, Division of Gynecologic Oncology, Department of Obstetrics & Gynecology, The Ohio State University, M210 Starling Loving 320 W 10th Ave, Columbus, OH 43210. E-mail: caroline.billingsley{at}osumc.edu.

Citation

Billingsley CC, Jacobson SN, Crafton SM, et al
Evaluation of the Hematologic Safety of Same Day Versus Standard Administration (24- to 72-Hour Delay) of Pegfilgrastim in Gynecology Oncology Patients Undergoing Cytotoxic Chemotherapy

Publication history

  • Received January 31, 2015
  • Accepted April 21, 2015
  • First published September 1, 2015.
Online issue publication 
September 01, 2015

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.